fill
Listen On

Podcast

The Clinical Utility of Guselkumab in Axial PsA

Host Amanda Mixon, President of RhAPP, is joined by Audrey Gibson, a Physician Assistant and fellow RhAPP member. They explore the clinical utility of guselkumab for treating axial psoriatic arthritis, a topic gaining significant interest in the rheumatology community.

Audrey shares insights from key clinical trials and offers practical advice on using IL-23 inhibitors in clinical practice. Whether you’re an experienced practitioner or new to the field, this discussion will enhance your understanding of the evolving treatment landscape.

Related Podcasts

podcast_img

CD64+ Binding Description, Relevance, and Potential Clinical Implications
podcast_img

Lost Time: The Impact of Delaying Optimal Therapy in RA & SpA Patients Without Disease Control
podcast_img

Biosimilars and The Patient Perspective
podcast_img

RhAPPcast: Biosimilars Unveiled - Empowering APPs for Better Patient Conversations
podcast_img

RhAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of PsA, PsO, and IBD
podcast_img

RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk
podcast_img

Navigating Remission in Rheumatoid Arthritis: Approaches, Advances, Impact, and Insights
VIEW ALL
sectionimg
dotsimg

Download the app and start using it now.

appstore Download on the App Store playstore GET IT ON Google Play